Namangale buzz drives MOZ demand

|

Published 30-OCT-2015 12:23 P.M.

|

1 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Mozambi Resources (ASX:MOZ) is now fully funded for an extended graphite hunt in Tanzania after raising $1.75 million in funding in a deal which was three times oversubscribed.

The ASX-listed graphite player recently announced a major graphite discovery at its newly-acquired Namangale prospect – part of the broader Nachingwea Project in Southern Tanzania.

It said that drilling at Namangale had firmed up that mineralisation occurs from surface and holes had intersected large intercepts including hits of up to 100m.

While assays from the drilling are due back in under a month, MOZ signalled that it would bring forward further drilling at Namangale in order to capture the momentum.

It said that the further drilling would focus on an area about 400m to the north east to try and extend the known mineralisation at Namangale, while diamond drilling would be used to firm up the coarse nature of the mineralisation hit.

It also said the drilling would firm up a JORC resource for Namangale.

Today it told investors that it had issued 50 million new shares to institutional and sophisticated clients at 3.5c each to raise $1.75 million.

MOZ said the offer was roughly three times oversubscribed, demonstrating the buzz MZ has been creating.

Want to read more on Mozambi Resources?

Mozambi hits major graphite discovery

Mozambi goes 15 from 15 in graphite chase

Mozambi adds for drilling to the schedule

tags

GRAPHITE


General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X